Generic Competition for Dimethyl Fumarate
Episode 20 min 5s

Generic Competition for Dimethyl Fumarate

Dr. Jason Crowell talks with 46brooklyn Research CEO Antonio Ciaccia about how Medicare Part D has hidden the benefits of generic competition for Tecfidera, a disease-modifying therapy for multiple sclerosis. Read the full article at 46brooklyn.com.

You May Also Like

Community discussion